Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of Epstein-Barr virus-associated diseases

Journal of Immunotherapy

Volumn 27, Issue 4, 2004, Pages 309-316

  Wilkie, Gwen M ^a   Taylor, Clare ^a   Jones, Marie M ^a   Burns, David M ^a   Turner, Marc ^b   Kilpatrick, David ^b   Amlot, Peter L ^c   Crawford, Dorothy H ^a   Haque, Tanzina ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cytotoxic T lymphocytes; Epstein Barr virus; Human; Immunotherapy

Indexed keywords

CD150 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HLA DR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ARTICLE; CANCER CELL DESTRUCTION; CELL KILLING; CRYOPRESERVATION; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL;

EID: 3042600551     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200407000-00007     Document Type: Article

References (31)

1. Rickinson AB, Callan MF, Annels NE. T-cell memory: lessons from Epstein-Barr virus infection in man. Phi Trans R Soc Lond. 2000;355:391-400.
2. Haque T, Crawford DH. The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation. Br J Haematol. 1999;106:309-316.
3. Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridisation studies in posttransplant lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis. 1985;152: 876-886.
4. Thomas JA, Hotchin N, Allday MJ, et al. Immunohistology of Epstein-Barr virus associated antigens in B cell disorders from immunocompromised individuals. Transplantation. 1990;49:944-953.
5. Armitage JM, Kormos RL, Stuart RS, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991;10: 877-887.
6. Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984;i:583-587.
7. Milpied N, Vasseur B, Parquet N, et al. Humanised anti-CD20 antibody (Rituximab) in posttransplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Anal Oncol. 2000;11(suppl. 1):113-116.
8. Rooney CM, Smith CA, Ng CYC, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet. 1995;345:9-13.
9. Khanna R, Bell S, Sherritt M, et al. Activatory and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc Natl Acad Sci USA. 1996;96:10391-10396.
10. Haque T, Taylor C, Wilkie GM, et al. Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein-Barr virus-specific cytotoxic T cells. Transplantation. 2001;72:1399-1402.
11. Haque T, Wilkie GM, Taylor C, et al. Treatment of Epstein-Barr virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet. 2002;360:436-442.
12. Riddell SR, Watanabe KS, Goodrich GM, et al. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science. 1992;257:238-241.
13. Rooney CM, Smith CA, Ng CYC, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 1998;92:1549-1555.
14. Haque T, Amlot PL, Helling N, et al. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol. 1998;160: 6204-6209.
15. Henle G, Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966;91:1248-1256.
16. Kilpatrick D, Darg C. Enzymatic modification of the lymphocyte surface. Application to tissue typing and rosetting with sheep erythrocytes. Tissue Antigens. 1983;21:309-317.
17. Tiwari J, Terasaki P. HLA and Disease Associations. New York: Springer-Verlag, 1985:14-17.
18. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225-235.
19. Olerup O, Zetterquist H. DR "low resolution" PCR-SSP typing: a correction and update. Tissue Antigens. 1993;41:55-56.
20. Miller G, Shope T, Lisco H, et al. Epstein-Barr virus: transformation, cytopathic changes and viral antigens in squirrel monkey and marmoset leucocytes. Proc Nat Acad Sci USA. 1972;69:383-387.
21. Klein E, Ben-Bassat H, Neumann H, et al. Properties of the K562 cell line, derived from a patient with chronic myeloid leukaemia. Int J Cancer. 1976;18:421-431.
22. Amlot PL, Tahami F, Dhinn DE, et al. Activation antigen expression on human T cells. 1 Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clin Exp Immunol. 1996;105: 176-182.
23. Jazwinska EC, Kilpatrick D. Haplotype frequencies in South-East Scotland. Tissue Antigens. 1987;29:115-119.
24. Straathof KC, Spencer DM, Sutton RE, et al. Suicide genes as safety switches in T lymphocytes. Cytotherapy. 2003;5:227-230.
25. Fast LD. The effect of exposing murine splenocytes to UVB light, psoralen plus UVA light, or gamma-irradiation on in vitro and in vivo immune responses. Transfusion. 2003;43:576-583.
26. Savoldo B, Goss J, Lui Z, et al. Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. Transplantation. 2001;72:1078-1086.
27. Orentas RJ, Lemas MV, Mullin MJ, et al. Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors. J Immunother. 1998;7:257-261.
28. Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today. 2000;21:515-521.
29. Baume DM, Caligiuri MA, Manley TJ, et al. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol. 1990;131:352-365.
30. + T lymphocytes. Nature. 2003; 421:852-855.
31. Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996;2:551-555.